Replies to post #7787 on Jiangbo Pharmaceuticals, Inc.(fka JGBO)

[jiangbro]

keekee--if you read the 8-k in my previous post's link, you'll find that Ernst and Young, independent *auditors* commissioned by the SEC to investigate Jiangbo, did resign because, amongst other things,

1) they were finding all sorts of inconsistencies (e.g. the company roster of employees listed a little over a dozen email addresses despite supposedly employing 456 people, the list of bank accounts being inconsistent with previous bank accounts identified by former CFO Elsa Sung, amongst other things, see p.19-20 of the June 7th 2011 8k exhibit 99.4, linked in previous post) and

2) under Cao's direction, "the Company refused to provide [to Ernst and Young as auditors] documents relating to the Company's sales, purchases, production and warehouse processes because the Company and the Company's legal counsel deemed those materials irrelevant to the investigation" (see p. 17 May 27, 2011 letter from same 8k exhibit 99.4)